Evidence map›Paper›PMID 36090984›Full record

ArticleFrontiers in immunology2022

Arabinogalactan enhances

Ye-Yu Li, Han-Mei Liu, Decheng Wang, Yan Lu, Cairong Ding, Li-Shuang Zhou, Xiang-Yang Wu, Zi-Wei Zhou, Shu-Qin Xu, Chen Lin and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Ye-Yu LiDepartment of Microbiology, School of Life Science, Fudan University, Shanghai, China.
Han-Mei LiuDepartment of Microbiology, School of Life Science, Fudan University, Shanghai, China.
Decheng WangSchool of Medicine, China Three Gorges University, Yichang, China.
Yan LuDepartment of Natural Medicine, School of Pharmacy, Fudan University, Shanghai, China.
Cairong DingSchool of Medicine, China Three Gorges University, Yichang, China.
Li-Shuang ZhouDepartment of Natural Medicine, School of Pharmacy, Fudan University, Shanghai, China.
Xiang-Yang WuShanghai Key Lab of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Zi-Wei ZhouDepartment of Microbiology, School of Life Science, Fudan University, Shanghai, China.
Shu-Qin XuDepartment of Microbiology, School of Life Science, Fudan University, Shanghai, China.
Chen LinDepartment of Microbiology, School of Life Science, Fudan University, Shanghai, China.
Lian-Hua QinShanghai Key Lab of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Yao LiState Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai, China.
Jun LiuDepartment of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Hai-Peng LiuShanghai Key Lab of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Lu ZhangDepartment of Microbiology, School of Life Science, Fudan University, Shanghai, China.
Tongji University · CNFudan University · CNChina Three Gorges University · CNUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arabinogalactan (AG) participates in forming the cell wall core of mycobacteria, a structure known as the mAGP complex. Few studies have reported the virulence of inartificial AG or its interaction with the host immune system. Using clustered regularly interspaced short palindromic repeats interference gene editing technology, conditional

Indexed as

Mycobacterium marinumAnimalsArabinoseGalactansGalactoseImmunity, InnateMiceVirulenceZebrafisharabinogalactanArabinoseGalactansGalactoseCRISPRiinnate immunitymacrophagesmycobacterial arabinogalactanvirulence

Identifiers

PMID36090984
PMCPMC9459032
OpenAlexW4293200057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.